Physician profile
Eugene Robert Stish
NPI 1891746962
$2,641.37
in general payments reported to CMS, 2019-2025
17 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.17 · 2020: $29.80 · 2021: $347 · 2022: $280 · 2023: $843 · 2024: $769 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,881 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,880.66 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $748.11 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $713.47 | 2020-2024 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals Lp | $243.23 | 2021-2025 | Breztri |
| Glaxosmithkline, LLC. | $229.25 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $121.68 | 2019-2021 | |
| Exact Sciences Corporation | $102.06 | 2024-2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $83.76 | 2024 | Austedo Xr |
| Bayer Healthcare Pharmaceuticals INC. | $66.68 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.59 | 2019-2023 | Stiolto Respimat |
| Axsome Therapeutics, INC. | $59.52 | 2024 | Auvelity |
| Amgen INC. | $48.05 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.55 | 2021-2022 | |
| Lilly USA, LLC | $45.00 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $27.07 | 2025 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $20.00 | 2023 | Spravato |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.12 | 2022 | |
| Alexion Pharmaceuticals, INC. | $13.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Stish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.